Status:
COMPLETED
Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen Lysinate
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
To investigate the relative bioavailability of ibuprofen from a (FDC) film-coated tablet of ibuprofen and caffeine vs. a tablet of ibuprofen (Brufen®) and a tablet of ibuprofen lysinate (Nurofen Immed...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Healthy male and female subjects
- Age 18 to 50 years
- Body mass index (BMI) 18.5 to 29.9 kg/m2
- Subjects must be able to understand and comply with study requirements
- Exclusion criteria:
- \- Any relevant deviation from healthy conditions
Exclusion
Key Trial Info
Start Date :
June 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT01879371
Start Date
June 1 2013
End Date
July 1 2013
Last Update
November 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1335.2.1 Boehringer Ingelheim Investigational Site
Ingelheim, Germany